Inhibitory effects of anthraquinones and bianthraquinones on Epstein-Barr virus activation

被引：36
|
作者：
Koyama, J [1 ]
Morita, I
Tagahara, K
Ogata, M
Mukainaka, T
Tokuda, H
Nishino, H
机构：
[1] Kobe Pharmaceut Univ, Fac Pharmaceut Sci, Kobe, Hyogo 658, Japan
[2] Kyoto Prefectural Univ Med, Dept Biochem, Kyoto 602, Japan
来源：
CANCER LETTERS | 2001年 / 170卷 / 01期
关键词：
anti-tumor promoting effect; Epstein-Barr virus activation; anthraquinone; bianthraquinone;
D O I：
10.1016/S0304-3835(01)00566-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Short-term in vitro assays for anti-tumor promoters were carried out for several anthraquinones and bianthraquinones, which were isolated from Cassia siamea and derived from cascaroside, A. Anthraquinone monomers showed higher anti-tumor promoting activity than that of bianthraquinones. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码：15 / 18
页数：4
相关论文
共 50 条
  • [31] ACTIVATION OF EPSTEIN-BARR VIRUS IN HYBRID-CELLS
    TSANG, KY
    HANN, WD
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1977, 58 (05) : 1295 - 1301
  • [32] ACTIVATION OF LYMPHOCYTES FROM EPSTEIN-BARR VIRUS-SERONEGATIVE DONORS BY AUTOLOGOUS EPSTEIN-BARR VIRUS-TRANSFORMED CELLS
    CHANG, RS
    CHANG, YY
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1980, 142 (02): : 156 - 162
  • [33] Epstein-Barr virus vectors for the treatment of Epstein-Barr virus-associated cancers
    Paillard, F
    [J]. HUMAN GENE THERAPY, 1998, 9 (08) : 1119 - 1120
  • [34] Serum Epstein-Barr virus DNA load in primary Epstein-Barr virus infection
    Bauer, CC
    Aberle, SW
    Popow-Kraupp, T
    Kapitan, M
    Hofmann, H
    Puchhammer-Stöckl, E
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2005, 75 (01) : 54 - 58
  • [35] Inhibitory effects of fatty acid monoesters of 2-O-β-D-glucosylglycerol on Epstein-Barr virus activation
    Colombo, D
    Scala, A
    Taino, IM
    Toma, L
    Ronchetti, F
    Tokuda, H
    Nishino, H
    Nagatsu, A
    Sakakibara, J
    [J]. CANCER LETTERS, 1998, 123 (01) : 83 - 86
  • [36] Inhibitory effects of monoacylated 2-O-β-galactosylglycerols on Epstein-Barr virus activation:: the significant role of the hexanoyl chain
    Colombo, D
    Compostella, F
    Ronchettia, F
    Scala, A
    Toma, L
    Mukainaka, T
    Nagatsu, A
    Konoshima, T
    Tokuda, H
    Nishino, H
    [J]. CANCER LETTERS, 1999, 143 (01) : 1 - 4
  • [37] CYTOLYTIC VIRUS ACTIVATION THERAPY FOR EPSTEIN-BARR VIRUS DRIVEN TUMOURS
    Greijer, A. E.
    Stoker, S. D.
    Novalic, Z.
    Malik, O.
    Verkuijlen, S. A. W. M.
    Juwana, H.
    Huitema, A. D. R.
    Tan, B. I.
    de Boer, J. P.
    Hutajulu, S. H.
    Kurnianda, J.
    Middeldorp, J. M.
    [J]. EUROPEAN JOURNAL OF CANCER, 2014, 50 : E44 - E44
  • [38] STUDIES ON INHIBITORS OF SKIN TUMOR PROMOTION .6. INHIBITORY EFFECTS OF QUINONES ON EPSTEIN-BARR VIRUS-ACTIVATION
    KONOSHIMA, T
    KOZUKA, M
    KOYAMA, J
    OKATANI, T
    TAGAHARA, K
    TOKUDA, H
    [J]. JOURNAL OF NATURAL PRODUCTS, 1989, 52 (05): : 987 - 995
  • [39] Epstein-Barr Virus and the Eye
    Cunningham, Emmett T.
    Zierhut, Manfred
    [J]. OCULAR IMMUNOLOGY AND INFLAMMATION, 2020, 28 (04) : 533 - 537
  • [40] Epstein-Barr virus in tumours
    Anagnostopoulos, I
    Hummel, M
    [J]. HISTOPATHOLOGY, 1996, 29 (04) : 297 - 315
12345